imatinib mesylate has been researched along with Anterior Optic Neuritis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bharatha, A; Lipton, JH; Montalban, X; Rotstein, DL; Sawicka, K | 1 |
| Cortes, J; Daver, NG; Jabbour, EJ; Kadia, TM; Kamiya-Matsuoka, C; Kantarjian, H; Konopleva, M; Mehta, RS; Naqvi, K; Rafei, H; Sinicrope, KD | 1 |
| Anupama, G; Attili, VS; Bapsy, PP; Govind Babu, K | 1 |
3 other study(ies) available for imatinib mesylate and Anterior Optic Neuritis
| Article | Year |
|---|---|
CNS demyelination after initiating the tyrosine kinase inhibitor imatinib: A report of two cases.
Topics: Aquaporin 4; Autoantibodies; Humans; Imatinib Mesylate; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Optic Neuritis; Protein Kinase Inhibitors | 2020 |
Neurotoxic events associated with BCR-ABL1 tyrosine kinase inhibitors: a case series.
Topics: Aged; Dasatinib; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Intervertebral Disc Degeneration; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Myelitis, Transverse; Optic Neuritis; Protein Kinase Inhibitors | 2019 |
Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia.
Topics: Antineoplastic Agents; Benzamides; Glucocorticoids; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Optic Neuritis; Piperazines; Prednisolone; Pyrimidines; Treatment Outcome; Vision Disorders | 2007 |